| 1. Dose to opposite breast |
| 2. treatment breaks for head and neck
retreatment rates |
| 3. Satisfaction |
| 4. None except protate seed implants. Insurances do not allow us to follow patients as long as we like.
|
| 5. Annual Internal Outcome Study 2004:prostate
2005:breast
integrated with tumor registry |
| 6. Stage 1 Larynx |
| 7. Ethyol Administration
Brachytherapy results
IMRT results |
| 8. We are tracking the post RT salivary function on our head and neck IMRT patients. |
| 9. Prostate cancer: 3D-conformal vs. IMRT
Breast, local, small: XRT vs. Mammosite vs. Intrabeam
Stereotactic Radiosurgery: CyberKnife vs. GammaKnife |
| 10. Prostate cancer: 3D-conformal vs. IMRT
Breast, local, small: XRT vs. Mammosite vs. Intrabeam
Stereotactic Radiosurgery: CyberKnife vs. GammaKnife |
| 11. see above for quality improvements |
| 12. Esophegeal protocol under study |
| 13. Morbidity and Mortality: unexpected deaths, interuption to treatments
AJCC Staging completeness
Patient Satisfaction Press Ganey |